Olanzapine plasma concentration, average daily dose, and interaction with co-medication in Schizophrenic patients

Thieme E-Books & E-Journals

Saved in:
Bibliographic Details
Main Authors: Bergemann, Niels (Author) , Frick, Alex (Author) , Parzer, Peter (Author) , Kopitz, Jürgen (Author)
Format: Article (Journal)
Language:German
Published: 29. März 2004
In: Pharmacopsychiatry
Year: 2004, Volume: 37, Issue: 2, Pages: 63-68
ISSN:1439-0795
DOI:10.1055/s-2004-815527
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-2004-815527
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-2004-815527
Get full text
Author Notes:N. Bergemann, A. Frick, P. Parzer, J. Kopitz

MARC

LEADER 00000caa a2200000 c 4500
001 1742835821
003 DE-627
005 20230427190907.0
007 cr uuu---uuuuu
008 201215s2004 xx |||||o 00| ||ger c
024 7 |a 10.1055/s-2004-815527  |2 doi 
035 |a (DE-627)1742835821 
035 |a (DE-599)KXP1742835821 
035 |a (OCoLC)1341383778 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a ger 
084 |a 33  |2 sdnb 
100 1 |a Bergemann, Niels  |e VerfasserIn  |0 (DE-588)170531007  |0 (DE-627)060634154  |0 (DE-576)131408437  |4 aut 
245 1 0 |a Olanzapine plasma concentration, average daily dose, and interaction with co-medication in Schizophrenic patients  |c N. Bergemann, A. Frick, P. Parzer, J. Kopitz 
264 1 |c 29. März 2004 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.12.2020 
520 |a Thieme E-Books & E-Journals 
700 1 |a Frick, Alex  |e VerfasserIn  |0 (DE-588)1223470555  |0 (DE-627)1742834442  |4 aut 
700 1 |a Parzer, Peter  |e VerfasserIn  |0 (DE-588)1030557837  |0 (DE-627)735716870  |0 (DE-576)378408712  |4 aut 
700 1 |a Kopitz, Jürgen  |e VerfasserIn  |0 (DE-588)1033923397  |0 (DE-627)743674472  |0 (DE-576)16530393X  |4 aut 
773 0 8 |i Enthalten in  |t Pharmacopsychiatry  |d Stuttgart [u.a.] : Thieme, 1984  |g 37(2004), 2, Seite 63-68  |h Online-Ressource  |w (DE-627)326977503  |w (DE-600)2041961-2  |w (DE-576)26359355X  |x 1439-0795  |7 nnas  |a Olanzapine plasma concentration, average daily dose, and interaction with co-medication in Schizophrenic patients 
773 1 8 |g volume:37  |g year:2004  |g number:2  |g pages:63-68  |g extent:6  |a Olanzapine plasma concentration, average daily dose, and interaction with co-medication in Schizophrenic patients 
856 4 0 |u https://doi.org/10.1055/s-2004-815527  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.thieme-connect.de/DOI/DOI?10.1055/s-2004-815527  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201215 
993 |a Article 
994 |a 2004 
998 |g 1033923397  |a Kopitz, Jürgen  |m 1033923397:Kopitz, Jürgen  |d 910000  |d 912000  |e 910000PK1033923397  |e 912000PK1033923397  |k 0/910000/  |k 1/910000/912000/  |p 4  |y j 
998 |g 1030557837  |a Parzer, Peter  |m 1030557837:Parzer, Peter  |d 910000  |d 910600  |e 910000PP1030557837  |e 910600PP1030557837  |k 0/910000/  |k 1/910000/910600/  |p 3 
998 |g 170531007  |a Bergemann, Niels  |m 170531007:Bergemann, Niels  |d 50000  |e 50000PB170531007  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1742835821  |e 3825712907 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["N. Bergemann, A. Frick, P. Parzer, J. Kopitz"]},"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"29. März 2004"}],"id":{"doi":["10.1055/s-2004-815527"],"eki":["1742835821"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"recId":"326977503","language":["eng"],"note":["Gesehen am 05.07.22"],"disp":"Olanzapine plasma concentration, average daily dose, and interaction with co-medication in Schizophrenic patientsPharmacopsychiatry","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"volume":"37","text":"37(2004), 2, Seite 63-68","extent":"6","year":"2004","pages":"63-68","issue":"2"},"pubHistory":["17.1984 -"],"title":[{"title_sort":"Pharmacopsychiatry","title":"Pharmacopsychiatry","subtitle":"clinical pharmacology, psychiatry, psychology, neurophysiology, neurobiology, gerontopsychiatry ; official organ of Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1439-0795"],"eki":["326977503"],"doi":["10.1055/s-00000054"],"zdb":["2041961-2"]},"origin":[{"dateIssuedDisp":"1984-","publisher":"Thieme","dateIssuedKey":"1984","publisherPlace":"Stuttgart [u.a.]"}]}],"person":[{"role":"aut","display":"Bergemann, Niels","roleDisplay":"VerfasserIn","given":"Niels","family":"Bergemann"},{"role":"aut","display":"Frick, Alex","roleDisplay":"VerfasserIn","given":"Alex","family":"Frick"},{"given":"Peter","family":"Parzer","role":"aut","roleDisplay":"VerfasserIn","display":"Parzer, Peter"},{"given":"Jürgen","family":"Kopitz","role":"aut","display":"Kopitz, Jürgen","roleDisplay":"VerfasserIn"}],"title":[{"title":"Olanzapine plasma concentration, average daily dose, and interaction with co-medication in Schizophrenic patients","title_sort":"Olanzapine plasma concentration, average daily dose, and interaction with co-medication in Schizophrenic patients"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 15.12.2020"],"language":["ger"],"recId":"1742835821"} 
SRT |a BERGEMANNNOLANZAPINE2920